• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MANUFACTURING INC CLINICAL CHEMISTRY TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MANUFACTURING INC CLINICAL CHEMISTRY TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT Back to Search Results
Catalog Number 06L45-21
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/26/2018
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed discrepant bilirubin results while using clinical chemistry total bilirubin reagents.The following data was provided.The customer uses normal range 0.2 to 1.2 mg/dl.(b)(6), initial (undiluted) 0.91 mg/dl, repeat (autodiluted) 1.77, 2.95 mg/dl.No impact to patient management was reported.
 
Event Description
Update september 5, 2018: the customer stated they suspect the neat results were correct, and the undiluted (neat) results were reported out of the lab.
 
Manufacturer Narrative
Evaluation of the customer issue included a complaint text review, a search for similar complaints, device history review, instrument log review, and labeling review.Returns were not available.No adverse trend was identified for the customer issue.Device history review did not identify any issues that may have caused the customer issue.Log review did not identify any issues that contributed to the customer issue.Labeling was reviewed and found to be adequate.Based on all available information and abbott diagnostics evaluation, no systemic issue was identified and no product deficiency was found.Describe event or problem was updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLINICAL CHEMISTRY TOTAL BILIRUBIN
Type of Device
TOTAL BILIRUBIN REAGENT
Manufacturer (Section D)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
MDR Report Key7724551
MDR Text Key115377697
Report Number1628664-2018-00617
Device Sequence Number1
Product Code CIG
UDI-Device Identifier00380740011369
UDI-Public00380740011369
Combination Product (y/n)N
PMA/PMN Number
K060574
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 09/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/26/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2019
Device Catalogue Number06L45-21
Device Lot Number52778UQ03
Was Device Available for Evaluation? No
Date Manufacturer Received09/05/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT C4000 ANALYZER; ARCHITECT C4000 ANALYZER; LN 02P24-40 SN C402059; LN 02P24-40 SN C402059
-
-